Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.64 |
| ▸ | NPY1R | P25929 | 7/20 | 0.64 |
| ▸ | NPY2R | P49146 | 5/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.64 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Elamipretide SCHEMBL17374160 | 1.00 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| Elamipretide SCHEMBL21627153 | 1.00 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| Elamipretide SCHEMBL17374162 | 1.00 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| Elamipretide SCHEMBL23192356 | 1.00 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| Elamipretide SCHEMBL15028020 | 1.00 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| Elamipretide SCHEMBL23842427 | 1.00 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| Elamipretide SCHEMBL18384105 | 1.00 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| Elamipretide SCHEMBL29414484 | 0.99 | NPY4R (0.63) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL18912830 | 0.99 | NPY4R (0.63) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL26179137 | 0.98 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5ROPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3087093-B1 | PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES | STEALTH BIOTHERAPEUTICS CORP (MC) | 2021-11-10 | — | — | EP | disclosed |
| US-10633415-B2 | Processes for preparing pharmaceutically relevant peptides | STEALTH BIOTHERAPEUTICS CORP (MC) | 2020-04-28 | — | — | US | disclosed |
| US-20180044378-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS INC. | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044378-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | ADM2, VIP, PEPD | NPY4R 135/4885NPY1R 140/4885NPY2R 76/4885 |
| US-10633415-B2 | Processes for preparing pharmaceutically relevant peptides | ADM2, VIP, PEPD | NPY4R 135/4885NPY1R 140/4885NPY2R 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.